271 related articles for article (PubMed ID: 12805562)
1. Evidence that mouse brain neuropathy target esterase is a lysophospholipase.
Quistad GB; Barlow C; Winrow CJ; Sparks SE; Casida JE
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7983-7. PubMed ID: 12805562
[TBL] [Abstract][Full Text] [Related]
2. Lysophospholipase inhibition by organophosphorus toxicants.
Quistad GB; Casida JE
Toxicol Appl Pharmacol; 2004 May; 196(3):319-26. PubMed ID: 15094302
[TBL] [Abstract][Full Text] [Related]
3. The homeostasis of phosphatidylcholine and lysophosphatidylcholine in nervous tissues of mice was not disrupted after administration of tri-o-cresyl phosphate.
Hou WY; Long DX; Wu YJ
Toxicol Sci; 2009 Jun; 109(2):276-85. PubMed ID: 19349639
[TBL] [Abstract][Full Text] [Related]
4. The homeostasis of phosphatidylcholine and lysophosphatidylcholine was not disrupted during tri-o-cresyl phosphate-induced delayed neurotoxicity in hens.
Hou WY; Long DX; Wang HP; Wang Q; Wu YJ
Toxicology; 2008 Oct; 252(1-3):56-63. PubMed ID: 18755237
[TBL] [Abstract][Full Text] [Related]
5. Neuropathy target esterase in mouse whole blood as a biomarker of exposure to neuropathic organophosphorus compounds.
Makhaeva GF; Rudakova EV; Sigolaeva LV; Kurochkin IN; Richardson RJ
J Appl Toxicol; 2016 Nov; 36(11):1468-75. PubMed ID: 26970094
[TBL] [Abstract][Full Text] [Related]
6. Toxicological and structural features of organophosphorus and organosulfur cannabinoid CB1 receptor ligands.
Segall Y; Quistad GB; Sparks SE; Nomura DK; Casida JE
Toxicol Sci; 2003 Nov; 76(1):131-7. PubMed ID: 12944586
[TBL] [Abstract][Full Text] [Related]
7. Subacute neurotoxicity induced in mice by potent organophosphorus neuropathy target esterase inhibitors.
Wu SY; Casida JE
Toxicol Appl Pharmacol; 1996 Jul; 139(1):195-202. PubMed ID: 8685903
[TBL] [Abstract][Full Text] [Related]
8. Further studies toward a mouse model for biochemical assessment of neuropathic potential of organophosphorus compounds.
Makhaeva GF; Rudakova EV; Hein ND; Serebryakova OG; Kovaleva NV; Boltneva NP; Fink JK; Richardson RJ
J Appl Toxicol; 2014 Dec; 34(12):1426-35. PubMed ID: 24395470
[TBL] [Abstract][Full Text] [Related]
9. Biosensor detection of neuropathy target esterase in whole blood as a biomarker of exposure to neuropathic organophosphorus compounds.
Makhaeva GF; Sigolaeva LV; Zhuravleva LV; Eremenko AV; Kurochkin IN; Malygin VV; Richardson RJ
J Toxicol Environ Health A; 2003 Apr; 66(7):599-610. PubMed ID: 12746135
[TBL] [Abstract][Full Text] [Related]
10. Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity.
Winrow CJ; Hemming ML; Allen DM; Quistad GB; Casida JE; Barlow C
Nat Genet; 2003 Apr; 33(4):477-85. PubMed ID: 12640454
[TBL] [Abstract][Full Text] [Related]
11. The alteration of the expression level of neuropathy target esterase in human neuroblastoma SK-N-SH cells disrupts cellular phospholipids homeostasis.
Hou WY; Song X; Wang Y; Chang P; Chen R; Wu YJ
Toxicol In Vitro; 2023 Feb; 86():105509. PubMed ID: 36336212
[TBL] [Abstract][Full Text] [Related]
12. Symposium introduction: retrospect and prospects for neuropathy target esterase (NTE) and the delayed polyneuropathy (OPIDP) induced by some organophosphorus esters.
Johnson MK
Chem Biol Interact; 1993 Jun; 87(1-3):339-46. PubMed ID: 8343991
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidylcholine hydrolases of human erythrocytes, lymphocytes, and brain: sensitive targets of conserved specificity for organophosphorus delayed neurotoxicants.
Vose SC; Holland NT; Eskenazi B; Casida JE
Toxicol Appl Pharmacol; 2007 Oct; 224(1):98-104. PubMed ID: 17663017
[TBL] [Abstract][Full Text] [Related]
14. Cellular function of neuropathy target esterase in lysophosphatidylcholine action.
Vose SC; Fujioka K; Gulevich AG; Lin AY; Holland NT; Casida JE
Toxicol Appl Pharmacol; 2008 Nov; 232(3):376-83. PubMed ID: 18706436
[TBL] [Abstract][Full Text] [Related]
15. Delayed neuropathy and inhibition of soluble neuropathy target esterase following the administration of organophosphorus compounds to hens.
Tian Y; Xie XK; Piao FY; Yamauchi T
Tohoku J Exp Med; 1998 Jul; 185(3):161-71. PubMed ID: 9823777
[TBL] [Abstract][Full Text] [Related]
16. Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy.
Lotti M; Moretto A; Capodicasa E; Bertolazzi M; Peraica M; Scapellato ML
Toxicol Appl Pharmacol; 1993 Oct; 122(2):165-71. PubMed ID: 8211998
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibitors of fatty acid amide hydrolase relative to neuropathy target esterase and acetylcholinesterase: toxicological implications.
Quistad GB; Sparks SE; Segall Y; Nomura DK; Casida JE
Toxicol Appl Pharmacol; 2002 Feb; 179(1):57-63. PubMed ID: 11884237
[TBL] [Abstract][Full Text] [Related]
18. The phosphorothioic acid O-(2-chloro-2,3,3-trifluorocyclobutyl) O-ethyl S-propyl ester exacerbates organophosphate polyneuropathy without inhibition of neuropathy target esterase.
Moretto A; Bertolazzi M; Lotti M
Toxicol Appl Pharmacol; 1994 Nov; 129(1):133-7. PubMed ID: 7974486
[TBL] [Abstract][Full Text] [Related]
19. Acetylcholinesterase and neuropathy target esterase inhibitions in neuroblastoma cells to distinguish organophosphorus compounds causing acute and delayed neurotoxicity.
Ehrich M; Correll L; Veronesi B
Fundam Appl Toxicol; 1997 Jul; 38(1):55-63. PubMed ID: 9268605
[TBL] [Abstract][Full Text] [Related]
20. The role of neurotoxic esterase (NTE) in the prevention and potentiation of organophosphorus-induced delayed neurotoxicity (OPIDN).
Pope CN; Tanaka D; Padilla S
Chem Biol Interact; 1993 Jun; 87(1-3):395-406. PubMed ID: 8343996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
